483
Vee Pak LLCFDA 483 - Vee Pak LLC - December 11, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an FDA inspection from December 6-11, 2023, Vee Pak LLC, a human drug manufacturer in Countryside, IL, was cited for deficiencies in its written stability program. The firm failed to provide adequate stability data to demonstrate the microbiological properties of several drug products remain acceptable throughout their labeled expiry period, indicating a significant quality control issue.
- Office
- Chicago District Office
- Person
Open in Dashboard
ID · 16c2fa6c-2ecc-4e51-a994-afa08003d47a